Additionally, cotreatment with AR-blocker BCT, produced a significant drop in LnCAP proliferation at 24 and 48 h, thus suggesting a putative add-on action of this drug in inhibiting AR-mediated PCa cell growth (see Figure 4B). This evidence concerns the gene AR and posterior cortical atrophy.